248 related articles for article (PubMed ID: 33164932)
1. Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis.
Li X; Xuan W; Chen D; Gao H; Wang G; Guo Q; Wang Y; Song H; Cai B
J Alzheimers Dis; 2020; 78(4):1315-1338. PubMed ID: 33164932
[TBL] [Abstract][Full Text] [Related]
2. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
Ribeiro VT; de Souza LC; Simões E Silva AC
Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
[TBL] [Abstract][Full Text] [Related]
3. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.
Gouveia F; Camins A; Ettcheto M; Bicker J; Falcão A; Cruz MT; Fortuna A
Ageing Res Rev; 2022 May; 77():101612. PubMed ID: 35346852
[TBL] [Abstract][Full Text] [Related]
4. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis.
Ye R; Hu Y; Yao A; Yang Y; Shi Y; Jiang Y; Zhang J
Int J Clin Pract; 2015 Jun; 69(6):674-81. PubMed ID: 25721930
[TBL] [Abstract][Full Text] [Related]
5. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.
Royea J; Hamel E
Geroscience; 2020 Oct; 42(5):1237-1256. PubMed ID: 32700176
[TBL] [Abstract][Full Text] [Related]
6. The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?
Kehoe PG
J Alzheimers Dis; 2018; 62(3):1443-1466. PubMed ID: 29562545
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
[TBL] [Abstract][Full Text] [Related]
8. [Angiotensin converting enzyme and Alzheimer's disease].
Kugaevskaia EV
Biomed Khim; 2013; 59(1):5-24. PubMed ID: 23650720
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Implications of Renin-Angiotensin System Modulators in Alzheimer's Dementia.
Ababei DC; Bild V; Macadan I; Vasincu A; Rusu RN; Blaj M; Stanciu GD; Lefter RM; Bild W
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765259
[TBL] [Abstract][Full Text] [Related]
10. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
[TBL] [Abstract][Full Text] [Related]
11. Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease.
Ashby EL; Kehoe PG
Expert Opin Investig Drugs; 2013 Oct; 22(10):1229-42. PubMed ID: 23800077
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology.
Kehoe PG; Hibbs E; Palmer LE; Miners JS
J Alzheimers Dis; 2017; 58(1):203-214. PubMed ID: 28387670
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Rescue Memory Defects in
Lee SH; Gomes SM; Ghalayini J; Iliadi KG; Boulianne GL
eNeuro; 2020; 7(6):. PubMed ID: 33060184
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin system and antihypertensive drugs in Alzheimer's disease: current standing of the angiotensin hypothesis?
Kehoe PG; Passmore PA
J Alzheimers Dis; 2012; 30 Suppl 2():S251-68. PubMed ID: 22330821
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin Converting Enzyme Inhibitors Ameliorate Brain Inflammation Associated with Microglial Activation: Possible Implications for Alzheimer's Disease.
Torika N; Asraf K; Roasso E; Danon A; Fleisher-Berkovich S
J Neuroimmune Pharmacol; 2016 Dec; 11(4):774-785. PubMed ID: 27562846
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor blocker use is associated with upregulation of the memory-protective angiotensin type 4 receptor (AT
Cosarderelioglu C; Nidadavolu LS; George CJ; Marx-Rattner R; Powell L; Xue QL; Tian J; Oh ES; Ferrucci L; Dincer P; Bennett DA; Walston JD; Abadir PM
Geroscience; 2023 Feb; 45(1):371-384. PubMed ID: 35969296
[TBL] [Abstract][Full Text] [Related]
17. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
Kehoe PG; Wilcock GK
Lancet Neurol; 2007 Apr; 6(4):373-8. PubMed ID: 17362841
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease.
Kehoe PG; Al Mulhim N; Zetterberg H; Blennow K; Miners JS
J Alzheimers Dis; 2019; 72(2):525-535. PubMed ID: 31594235
[TBL] [Abstract][Full Text] [Related]
19. Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.
O'Hagan TS; Wharton W; Kehoe PG
Am J Neurodegener Dis; 2012; 1(3):266-79. PubMed ID: 23383397
[TBL] [Abstract][Full Text] [Related]
20. Targeting Renin-Angiotensin System Against Alzheimer's Disease.
Gebre AK; Altaye BM; Atey TM; Tuem KB; Berhe DF
Front Pharmacol; 2018; 9():440. PubMed ID: 29760662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
